missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MDR-1339, MedChemExpress
MedChemExpress MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.
Brand: Medchem Express HY-14503
This item is not returnable.
View return policy
Description
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.Specifications
| MDR-1339 | |
| White | |
| C20H22O4 | |
| DWK-1339 | |
| COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1 | |
| 326.39 | |
| Research | |
| Neuroscience-Neurodegeneration |
| 1018946-38-7 | |
| Research | |
| 5 mg | |
| DMSO : 50 mg/mL (153.19 mM; Need ultrasonic) | |
| 326.39 | |
| 98.03% | |
| Solid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
MDR-1339, MedChemExpress
Research purposes only
Spot an opportunity for improvement?Share a Content Correction
